ACA International Advocates for CFPB Reforms and Credit Reporting Integrity

ACA International is actively pushing a two‑track agenda right now: (1) structural and procedural reforms at the CFPB, and (2) “integrity” in credit reporting, especially around efforts to suppress or limit medical debt data. Here’s how those pieces fit together based on their recent litigation and public filings.

ACA’s stance on CFPB reforms

ACA has aligned itself with challengers to recent CFPB actions that restrict the use of medical debt in credit reporting and underwriting. In ACA International et al. v. CFPB, trade groups and industry plaintiffs seek to block enforcement of a CFPB regulation that bars medical debt from consumer credit reports and prohibits lenders from using medical information in credit decisions. They argue this rule exceeds the Bureau’s statutory authority under the Administrative Procedure Act and raises constitutional issues, including Appropriations Clause and First Amendment concerns.

From ACA’s perspective, this is framed as a structural and process problem at the CFPB: they characterize the Bureau as using guidance and rulemaking to effectively rewrite the Fair Credit Reporting Act (FCRA) without clear congressional authorization. In their pleadings, they ask courts not just to vacate the specific “medical debt rule” but to reaffirm limits on the CFPB’s power to reshape core elements of the national credit reporting system.

“Credit reporting integrity” as ACA defines it

In both federal and state litigation, ACA’s core theme is that laws or rules that suppress accurate medical debt information undermine the “integrity” of the system Congress built in the FCRA. In their Colorado suit (ACA International v. Fulford), ACA attacks HB 23‑1126, which directs CRAs to suppress truthful information about unpaid medical bills from consumer reports. They assert that:

• The FCRA was designed to support a national system that promotes transparency and efficiency in lending decisions based on credit reports.

• Colorado’s law, by mandating suppression of accurate data (an estimated 57% of reported accounts, according to the complaint), makes reports “far less useful and reliable” and conflicts with federal standards.

• When medical debts are invisible to the credit reporting system, the risk does not disappear; it shifts into litigation, collections, or bankruptcy, which ACA argues is worse for consumers and creditors and distorts risk pricing.

So when ACA says it is defending “credit reporting integrity,” it is advocating for:

• Continued reporting of accurate negative information (including medical debts).

• Preemption of state rules that carve medical debt out of traditional FCRA‑style reporting.

• Limits on federal agency (CFPB) rules that prohibit creditors from using medical information in underwriting.

How ACA’s view contrasts with consumer advocates

Consumer and legal aid groups generally define “integrity” around accuracy, fairness, and error correction, rather than completeness of negative data. For example, NCLC describes its credit reporting work as pushing for “accuracy, fairness, privacy, and holding companies accountable when they violate the law.” Others focus on the massive error problem and call for stronger accuracy standards and more effective dispute rights under the FCRA.

Here is a simplified contrast in how “integrity” is framed:

Why ACA is litigating both CFPB and state rules

ACA’s recent filings show a coordinated strategy to challenge both federal and state efforts that narrow the reporting or use of medical debt:

• At the federal level, they argue the CFPB’s “Medical Debt Rule” conflicts with the FCRA’s allowance for medical debt reporting and use, and is procedurally and constitutionally defective.

• At the state level (Colorado HB 23‑1126), they argue the state has “shut down” a legal avenue of conveying credit risk information by forbidding CRAs from reporting medical debt, in conflict with FCRA’s national standards, and that this is also an impermissible content‑based speech restriction.

They present both as necessary to “restore the federal balance and protect information transparency in financial services,” positioning themselves as defending the continuity of a nationwide credit reporting architecture that relies on broad data inputs, including medical obligations.

Given your regulatory lens, the practical takeaway is that ACA is using “CFPB reform” language largely in service of reining in medical‑debt‑specific interventions that, in their view, rewrite FCRA’s basic completeness‑of‑data model rather than incrementally tightening accuracy and dispute‑resolution standards.